We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hits Puerto Rican Drugmaker With Form 483
The FDA has slapped Puerto Rico-based AIAC Pharma with a six-observation Form 483 over complaint management, cleaning records and apparent lapses in laboratory controls.